高级搜索

生血丸治疗胃肠肿瘤化疗所致血象下降的临床疗效观察

Clinical Efficacy Observation of Shengxue Pill in Treating Changes of Hematology of Chemotherapy in Gastrointestinal Cancer

  • 摘要: 目的 探讨生血丸用于治疗胃肠肿瘤化疗所致血象下降的临床疗效。方法 将116例胃肠肿瘤化疗患者随机分为两组,治疗组59例采用生血丸联合化疗治疗,对照组57例单纯化疗,评价两组患者化疗后第7、14、21、28天的血象变化情况。结果 治疗组化疗后血象下降的控制率均优于对照组,差异具有统计学意义(P<0.05);而且在生活质量、中医证候改善等方面治疗组也优于对照组(P<0.05)。结论 生血丸预防胃肠肿瘤化疗所致血象下降疗效确切,安全可靠。

     

    Abstract: Objective To explore the clinical efficacy of Shengxue pill in treating the changes of hematology of chemotherapy.MethodOne hundred and sixteen patients with gastrointestinal cancer were randomly divided into treatment group and control group.The treatment group was given combination therapy Shengxue pill and chemotherapy,and the control group was given chemotherapy alone.The changes of hematology were evaluated on the seventh day,fourteenth day,twenty-first day,and twenty-eighth day of chemotherapy.The QOL and some symptoms related to the Deficiency of Yang of Both Spleen and Kidney were evaluated as well. Results The total effective rate of the decrease of hematology of HGB,WBC,PLT in the treatment group was significantly lower than that of the control group.The QOL and the control of symptoms related to the Deficiency of Yang of Both Spleen and Kidney were better than that of the control group. Conclusion The clinical efficacy of Shengxue pill in treating the changes of hematology of chemotherapy is accurate,safe and reliable.

     

/

返回文章
返回